ambrisentan accord 10 mg film-coat. tabl.
accord healthcare b.v. - ambrisentan 10 mg - film-coated tablet - ambrisentan
ambrisentan accord 5 mg film-coat. tabl.
accord healthcare b.v. - ambrisentan 5 mg - film-coated tablet - ambrisentan
ambrisentan ab 10 mg film-coat. tabl.
aurobindo sa-nv - ambrisentan 10 mg - film-coated tablet - ambrisentan
ambrisentan ab 5 mg film-coat. tabl.
aurobindo sa-nv - ambrisentan 5 mg - film-coated tablet - ambrisentan
teva-ambrisentan tablet
teva canada limited - ambrisentan - tablet - 5mg - ambrisentan 5mg
teva-ambrisentan tablet
teva canada limited - ambrisentan - tablet - 10mg - ambrisentan 10mg
ambrritan 10 tablet
surgilinks ltd & stallion laboratories pvt. ltd p.o box 14461 - 00800, nairobi - ambrisentan - tablet - 10mg - ambrisentan
ambrritan 5 tablet
surgilinks ltd c/o stallion laboratories pvt ltd p.o. box 14461 - 00800, nairobi - ambrisentan - tablet - 5mg - ambrisentan
sentavenir 10
bioavenir ltd, israel - ambrisentan - film coated tablets - ambrisentan 10 mg - ambrisentan - sentavenir is indicated for treatment of pulmonary arterial hypertension (pah) in adult patients of: who functional class (fc) ii to iii, including use in combination treatment with tadalafil. efficacy has been shown in idiopathic pah (ipah) and in pah associated with connective tissue disease.
sentavenir 5
bioavenir ltd, israel - ambrisentan - film coated tablets - ambrisentan 5 mg - ambrisentan - sentavenir is indicated for treatment of pulmonary arterial hypertension (pah) in adult patients of: who functional class (fc) ii to iii, including use in combination treatment with tadalafil. efficacy has been shown in idiopathic pah (ipah) and in pah associated with connective tissue disease.